FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael B. Murphy

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Naveed Sattar; Heather M Murray; Paul Welsh; Gerard J Blauw; Brendan M Buckley; Stuart Cobbe; Anton J M de Craen; GD Lowe; J Wouter Jukema; Peter W Macfarlane; Michael B. Murphy; David J Stott; Rudi G J Westendorp; James Shepherd; Ian Ford; Chris J Packard
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Naveed Sattar; Heather M Murray; P Welsh; Gerard J Blauw; Brendan M Buckley; Anton J M de Craen; Ian Ford; Nita G Forouhi; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Michael B. Murphy; Chris J Packard; David J Stott; R G J Westendorp; James Shepherd
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly.
Eliana Polisecki; Inga Peter; Michele Robertson; Alex D McMahon; Ian Ford; Christopher Packard; James Shepherd; J Wouter Jukema; Gerard J Blauw; Rudi G J Westendorp; Anton J M de Craen; Stella Trompet; Brendan M Buckley; Michael B. Murphy; Jose Ordovas; Ernst Schaefer
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael B. Murphy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Naveed Sattar; Heather M Murray; Paul Welsh; Gerard J Blauw; Brendan M Buckley; Stuart Cobbe; Anton J M de Craen; GD Lowe; J Wouter Jukema; Peter W Macfarlane; Michael B. Murphy; David J Stott; Rudi G J Westendorp; James Shepherd; Ian Ford; Chris J Packard
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
PLoS medicine 2009;6(6):e1000099.
2009: Naveed Sattar; Heather M Murray; P Welsh; Gerard J Blauw; Brendan M Buckley; Anton J M de Craen; Ian Ford; Nita G Forouhi; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Michael B. Murphy; Chris J Packard; David J Stott; R G J Westendorp; James Shepherd
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly.
Diabetologia 2009;52(2):235-9.
2008: Eliana Polisecki; Inga Peter; Michele Robertson; Alex D McMahon; Ian Ford; Christopher Packard; James Shepherd; J Wouter Jukema; Gerard J Blauw; Rudi G J Westendorp; Anton J M de Craen; Stella Trompet; Brendan M Buckley; Michael B. Murphy; Jose Ordovas; Ernst Schaefer
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.
Atherosclerosis 2008;200(1):95-101.
2008: S Trompet; Anton J M de Craen; P Eline Slagboom; James Shepherd; Gerard J Blauw; Michael B. Murphy; E L E M Bollen; Brendan M Buckley; Ian Ford; Allan Gaw; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; J Wouter Jukema
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.
Experimental gerontology 2008;43(8):801-5.
2008: Naveed Sattar; Alex McConnachie; A Gerald Shaper; Gerard J Blauw; Brendan M Buckley; Anton J M de Craen; Ian Ford; Nita G Forouhi; Dilys J Freeman; J Wouter Jukema; Lucy Lennon; Peter W Macfarlane; Michael B. Murphy; Chris J Packard; David J Stott; Rudi G J Westendorp; Peter H Whincup; James Shepherd; S Goya Wannamethee
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
Lancet 2008;371(9628):1927-35.
2008: S Trompet; Anton J M de Craen; P Slagboom; J Shepherd; G J Blauw; Michael B. Murphy; E L E M Bollen; B M Buckley; I Ford; A Gaw; P W Macfarlane; C J Packard; D J Stott; J W Jukema; Rudi G J Westendorp
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study.
Brain : a journal of neurology 2008;131(Pt 4):1069-77.
2007: Chris J Packard; Rudi G J Westendorp; David J Stott; Muriel J Caslake; Heather M Murray; James Shepherd; Gerard J Blauw; Michael B. Murphy; E L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; Jelle Jolles; Ivan J Perry; Brian J Sweeney; Cillian Twomey
Association between apolipoprotein E4 and cognitive decline in elderly adults.
Journal of the American Geriatrics Society 2007;55(11):1777-85.
2007: S Trompet; Douwe Pons; Anton J M de Craen; P Eline Slagboom; James Shepherd; Gerard J Blauw; Michael B. Murphy; Stuart M Cobbe; E L E M Bollen; Brendan M Buckley; Ian Ford; Michael Hyland; Allan Gaw; Peter W Macfarlane; Chris J Packard; John Norrie; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp; J Wouter Jukema
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study.
Annals of the New York Academy of Sciences 2007;1100():189-98.
2007: Naveed Sattar; Heather M Murray; Alex McConnachie; Gerard J Blauw; E L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; Michael B. Murphy; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp; James Shepherd
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Circulation 2007;115(8):981-9.
2006: Helen Jones; Greg Atkinson; Andrew Leary; Keith George; Michael B. Murphy; Jim Waterhouse
Reactivity of ambulatory blood pressure to physical activity varies with time of day.
Hypertension 2006;47(4):778-84.
2005: Chris J Packard; Ian Ford; Michele Robertson; James Shepherd; Gerard J Blauw; Michael B. Murphy; E L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
Circulation 2005;112(20):3058-65.
2004: Athanasios J Manolis; John L Reid; Dick de Zeeuw; Michael B. Murphy; Elke Seewaldt-Becker; Jürgen Köster
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Journal of hypertension 2004;22(5):1033-7.
2002: James Shepherd; Gerard J Blauw; Michael B. Murphy; E L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
Lancet 2002;360(9346):1623-30.
2002: Peter Houx; James Shepherd; Gerard J Blauw; Michael B. Murphy; Ian Ford; E L E M Bollen; Brendan M Buckley; David J Stott; W Jukema; Michael Hyland; Allan Gaw; John Norrie; Adriaan M Kamper; Ivan J Perry; Peter W Macfarlane; A Edo Meinders; Brian J Sweeney; Chris J Packard; Cillian Twomey; Stuart M Cobbe; Rudi G J Westendorp
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk.
Journal of neurology, neurosurgery, and psychiatry 2002;73(4):385-9.
2002: Andrew C Leary; Peter T Donnan; Thomas M MacDonald; Michael B. Murphy
The white-coat effect is associated with increased blood pressure reactivity to physical activity.
Blood pressure monitoring 2002;7(4):209-13.
2002: Andrew C Leary; Alan D Struthers; Peter T Donnan; Thomas M MacDonald; Michael B. Murphy
The morning surge in blood pressure and heart rate is dependent on levels of physical activity after waking.
Journal of hypertension 2002;20(5):865-70.
2002: John B Kostis; Stuart M Cobbe; Colin Johnston; Ian Ford; Michael B. Murphy; Michael A Weber; Henry R Black; Pierre-François Plouin; Daniel Levy; Guiseppe Mancia; Pierre Larochelle; Rainer E Kolloch; Michael H Alderman; Luis M Ruilope; Björn Dahlöf; John M Flack; Robert Wolf
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial.
American journal of hypertension 2002;15(2 Pt 1):193-8.
2001: Johan D Lefrandt; J Heitmann; Knut Sevre; M Castellano; M Hausberg; M Fallon; A Urbigkeit; Morten Rostrup; E Agabiti-Rosei; K H Rahn; Michael B. Murphy; Faiez Zannad; Pieter J de Kam; Andries J Smit
Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
British journal of clinical pharmacology 2001;52(6):687-92.
2001: Michael B. Murphy; C Murray; George D Shorten
Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.
The New England journal of medicine 2001;345(21):1548-57.
2001: Johan D Lefrandt; J Heitmann; Knut Sevre; M Castellano; M Hausberg; M Fallon; L Fluckiger; A Urbigkeit; Morten Rostrup; E Agabiti-Rosei; K H Rahn; Michael B. Murphy; Faiez Zannad; Pieter J de Kam; Arie M Van Roon; Andries J Smit
The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
American journal of hypertension 2001;14(11 Pt 1):1083-9.
2001: Gerard J Blauw; James Shepherd; Michael B. Murphy
Dementia and statins. PROSPER study group.
Lancet 2001;357(9259):881.
2000: Andrew C Leary; Peter T Donnan; T M MacDonald; Michael B. Murphy
The influence of physical activity on the variability of ambulatory blood pressure.
American journal of hypertension 2000;13(10):1067-73.
2000: J Conor O'Shea; Michael B. Murphy
Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping?
American journal of hypertension 2000;13(6 Pt 1):601-6.
2000: Niall Colwell; Brendan M Buckley; Michael B. Murphy
Unstable angina pectoris.
The New England journal of medicine 2000;342(22):1676-7; author reply 1678.
2000: Michael B. Murphy
Dopamine: a role in the pathogenesis and treatment of hypertension.
Journal of human hypertension 2000;14 Suppl 1():S47-50.
2000: J Conor O'Shea; Michael B. Murphy
Electronic activity-monitor-derived sleeping and awake times and diurnal variation of blood pressure.
Blood pressure monitoring 2000;5(2):65-8.
2000: J Conor O'Shea; Michael B. Murphy
Ambulatory blood pressure monitoring: which arm?
Journal of human hypertension 2000;14(4):227-30.
2000: Andrew C Leary; Peter T Donnan; Thomas M MacDonald; Michael B. Murphy
Physical activity level is an independent predictor of the diurnal variation in blood pressure.
Journal of hypertension 2000;18(4):405-10.
1999: James Shepherd; Gerard J Blauw; Michael B. Murphy; Stuart M Cobbe; E L E M Bollen; Brendan M Buckley; Ian Ford; J Wouter Jukema; Michael Hyland; Allan Gaw; A Margot Lagaay; Ivan J Perry; Peter W Macfarlane; A Edo Meinders; Brian J Sweeney; Chris J Packard; Rudi G J Westendorp; Cillian Twomey; David J Stott
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.
The American journal of cardiology 1999;84(10):1192-7.
1999: Damian B Murphy; Michael B. Murphy
Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism.
Journal of cardiovascular pharmacology 1999;33(1):122-5.
1997: Damian B Murphy; A Sutton; L F Prescott; Michael B. Murphy
A comparison of the effects of tramadol and morphine on gastric emptying in man.
Anaesthesia 1997;52(12):1224-9.
1997: Damian B Murphy; J A Sutton; L F Prescott; Michael B. Murphy
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
Anesthesiology 1997;87(4):765-70.
1997: Carl J Vaughan; Norman Delanty; H Harrington; Michael B. Murphy
Treatment of spastic dystonia with transdermal nicotine.
Lancet 1997;350(9077):565.
1997: C C Cronin; TM Higgins; Michael B. Murphy; JB Ferriss
Supervised drug administration in patients with refractory hypertension unmasking noncompliance.
Postgraduate medical journal 1997;73(858):239-40.
1997: Carl J Vaughan; M Gallagher; Michael B. Murphy
Left ventricular myxoma presenting with constitutional symptoms and raised serum interleukin-6 both suppressed by naproxen.
European heart journal 1997;18(4):703.
1997: J Conor O'Shea; Michael B. Murphy
Factors confounding assessment of ambulatory blood pressure monitors, studied during formal evaluation of the Tycos Quiet-Trak.
American journal of hypertension 1997;10(2):175-80.
1997: Joseph Foss; Michael F O'Connor; Chun-Su Yuan; Michael B. Murphy; Jonathan Moss; Michael F Roizen
Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study.
Journal of clinical pharmacology 1997;37(1):25-30.
1996: Carl J Vaughan; Michael B. Murphy; B M Buckley
Statins do more than just lower cholesterol.
Lancet 1996;348(9034):1079-82.
1995: H P Singh; E T Coleman; M Hargrove; S E Barrow; Michael B. Murphy; T Aherne
Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass.
The Annals of thoracic surgery 1995;59(3):647-50.
1995: B P Cholley; Sanjeev G Shroff; J Sandelski; Claudia E Korcarz; B A Balasia; S Jain; David S Berger; Michael B. Murphy; R H Marcus; Roberto M Lang
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
Circulation 1995;91(4):1052-62.
1994: Carl J Vaughan; Michael B. Murphy
The use of ambulatory blood pressure monitoring in the evaluation of racial differences in blood pressure.
Journal of cardiovascular risk 1994;1(2):132-5.
1994: R H Marcus; Claudia E Korcarz; G McCray; A Neumann; Michael B. Murphy; K Borow; Lynn Weinert; James E Bednarz; D D Gretler; Kirk T Spencer
Noninvasive method for determination of arterial compliance using Doppler echocardiography and subclavian pulse tracings. Validation and clinical application of a physiological model of the circulation.
Circulation 1994;89(6):2688-99.
1994: D D Gretler; M T Fumo; K S Nelson; Michael B. Murphy
Ethnic differences in circadian hemodynamic profile.
American journal of hypertension 1994;7(1):7-14.
1993: B L Pilmer; J A Green; Edward A Panacek; W J Elliot; Michael B. Murphy; W Rutherford; A R Nara
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension.
Journal of clinical pharmacology 1993;33(6):549-53.
1993: W J Elliott; W B Martin; Michael B. Murphy
Comparison of two noninvasive screening tests for renovascular hypertension.
Archives of internal medicine 1993;153(6):755-64.
1993: K M Borow; A Neumann; Roberto M Lang; D Ehler; B Valentine-Bates; A Wolff; K Friday; Michael B. Murphy
Noninvasive assessment of the direct action of oral nifedipine and nicardipine on left ventricular contractile state in patients with systemic hypertension: importance of reflex sympathetic responses.
Journal of the American College of Cardiology 1993;21(4):939-49.
1993: D D Gretler; G F Carlson; A V Montano; Michael B. Murphy
Diurnal blood pressure variability and physical activity measured electronically and by diary.
American journal of hypertension 1993;6(2):127-33.
1993: C M Oliner; W J Elliott; D D Gretler; Michael B. Murphy
Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension.
Journal of human hypertension 1993;7(1):65-70.
1992: D D Gretler; W J Elliott; Mauro Moscucci; R W Childers; Michael B. Murphy
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
Archives of internal medicine 1992;152(12):2445-8.
1992: Michael B. Murphy
Selecting optimum antihypertensive therapy: indications for choosing a calcium channel blocker.
The American journal of medicine 1992;93(2A):38S-44S.
1992: Michael B. Murphy
Blood pressure and fitness for work.
American journal of hypertension 1992;5(5 Pt 1):253-6.
1992: M T Fumo; S Teeger; Roberto M Lang; James E Bednarz; P Sareli; Michael B. Murphy
Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks.
American journal of hypertension 1992;5(3):111-6.
1992: D D Gretler; K C Jones; Michael B. Murphy
5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
The Journal of pharmacology and experimental therapeutics 1992;260(2):491-8.
1991: Michael B. Murphy; M T Fumo; D D Gretler; K S Nelson; Roberto M Lang
Diurnal blood pressure variation: differences among disparate ethnic groups.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(8):S45-7.
1991: W J Elliott; R R Weber; Michael B. Murphy
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide.
Journal of clinical pharmacology 1991;31(8):751-7.
1991: M A Winker; Michael B. Murphy
Isolated systolic hypertension in the elderly.
JAMA : the journal of the American Medical Association 1991;265(24):3301-2.
1991: D D Gretler; G P Gramelspacher; M T Fumo; W J Elliott; Michael B. Murphy
Influence of diuretic therapy on the clonidine suppression test.
Journal of clinical pharmacology 1991;31(5):448-54.
1991: J D Kohli; J L McNay; S I Rajfer; Michael B. Murphy
Peripheral dopamine receptors in cardiovascular therapy. The legacy of Leon Goldberg (1927-1989).
Hypertension 1991;17(5):700-6.
1991: W J Elliott; Michael B. Murphy; R Karp
Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1991;10(3):373-9.
1991: W J Elliott; T A Karnezis; R A Silverman; J Geanon; Ramesh C Tripathi; Michael B. Murphy
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans.
Clinical pharmacology and therapeutics 1991;49(3):285-93.
1991: A S Bass; Michael B. Murphy
Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion.
Clinical and experimental hypertension. Part A, Theory and practice 1991;13(6-7):1127-51.
1990: W J Elliott; T B Polascik; Michael B. Murphy
Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor.
Journal of human hypertension 1990;4(6):717-23.
1990: P T Horn; Michael B. Murphy
New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy.
Drugs 1990;40(4):487-92.
1990: P T Horn; Michael B. Murphy
Therapeutic applications of drugs acting on peripheral dopamine receptors.
Journal of clinical pharmacology 1990;30(8):674-9.
1990: C S Greene; D D Gretler; K Cervenka; C E McCoy; F D Brown; Michael B. Murphy
Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine.
The American journal of emergency medicine 1990;8(4):293-6.
1990: A S Bass; Michael B. Murphy
Role of endogenous dopamine in the natriuresis accompanying various sodium challenges.
American journal of hypertension 1990;3(6 Pt 2):90S-92S.
1990: Michael B. Murphy; A S Bass
Dopamine, its receptors, and atrial natriuretic peptide.
American journal of hypertension 1990;3(6 Pt 2):55S-58S.
1990: W J Elliott; R R Weber; K S Nelson; C M Oliner; M T Fumo; D D Gretler; G R McCray; Michael B. Murphy
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
Circulation 1990;81(3):970-7.
1990: Michael B. Murphy
Clinical use of dopamine receptor agonists.
Proceedings of the Western Pharmacology Society 1990;33():31-5.
1990: Michael B. Murphy; W J Elliott
Dopamine and dopamine receptor agonists in cardiovascular therapy.
Critical care medicine 1990;18(1 Pt 2):S14-8.
1989: T A Karnezis; Brenda J Tripathi; G Dawson; Michael B. Murphy; Ramesh C Tripathi
Effects of dopamine receptor activation on the level of cyclic AMP in the trabecular meshwork.
Investigative ophthalmology & visual science 1989;30(6):1090-4.
1989: A S Bass; Michael B. Murphy; J D Kohli; L I Goldberg
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug.
Journal of cardiovascular pharmacology 1989;13(4):667-71.
1989: C M Oliner; Michael B. Murphy
Beta-blockade and mental performance.
Archives of internal medicine 1989;149(2):474-5.
1989: W J Elliott; Michael B. Murphy; Francis H Straus; J Jarabak
Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.
Archives of internal medicine 1989;149(1):214-6.
1988: T A Karnezis; Michael B. Murphy
Dopamine receptors and intraocular pressure.
Trends in pharmacological sciences 1988;9(11):389-90.
1988: T A Karnezis; Michael B. Murphy; R R Weber; K S Nelson; Brenda J Tripathi; Ramesh C Tripathi
Effects of selective dopamine-1 receptor activation on intraocular pressure in man.
Experimental eye research 1988;47(5):689-97.
1988: Lewis B Schwartz; M G Bissell; Michael B. Murphy; Bruce Gewertz
Renal effects of dopamine in vascular surgical patients.
Journal of vascular surgery 1988;8(4):367-74.
1988: Michael B. Murphy; A S Bass; L I Goldberg
Renal effects of atrial natriuretic factor are independent of dopamine1 receptors.
The American journal of physiology 1988;255(3 Pt 2):F494-9.
1988: Roberto M Lang; K M Borow; A Neumann; J D Carroll; Lynn Weinert; Michael B. Murphy; Jalal K Ghali; S I Rajfer
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
The American journal of cardiology 1988;62(5):46C-52C.
1988: K S Nelson; R R Weber; W J Elliott; D Zebrauskas; Michael B. Murphy
Evaluation of the Suntech Accutracker. A novel noninvasive ambulatory blood pressure monitor.
American journal of hypertension 1988;1(3 Pt 3):121S-123S.
1988: Michael B. Murphy; R R Weber; K Nelson; L I Goldberg
The role of alpha-adrenoceptor blockade in the antihypertensive effects of fenoldopam in humans.
Clinical pharmacology and therapeutics 1988;44(1):49-55.
1988: W J Elliott; Michael B. Murphy
Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels.
The American journal of medicine 1988;84(3 Pt 1):419-24.
1988: G L Bakris; R R Weber; K Nelson; W J Elliott; E Kaplan; Michael B. Murphy
Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
Mineral and electrolyte metabolism 1988;14(6):343-6.
1988: R R Weber; C E McCoy; J A Ziemniak; E D Frederickson; L I Goldberg; Michael B. Murphy
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.
British journal of clinical pharmacology 1988;25(1):17-21.
1987: Michael B. Murphy; C E McCoy; R R Weber; E D Frederickson; F L Douglas; L I Goldberg
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
Circulation 1987;76(6):1312-8.
1987: L I Goldberg; Michael B. Murphy
Potential use of DA1 and DA2 receptor agonists in the treatment of hypertension.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(5-6):1023-35.
1985: A D Struthers; Michael B. Murphy; C T Dollery
Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus.
Hypertension 1985;7(6 Pt 2):II95-101.
1985: Michael B. Murphy; M A Orchard; E L Conway; S E Barrow
The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin.
European journal of clinical pharmacology 1985;29(4):413-6.
1985: Michael B. Murphy
Treatment of hypertension with calcium antagonists.
International journal of clinical pharmacology research 1985;5(5):287-91.
1984: D J Heavey; P Lumley; S E Barrow; Michael B. Murphy; P P Humphrey; C T Dollery
Effects of intravenous infusions of prostaglandin D2 in man.
Prostaglandins 1984;28(6):755-67.
1984: Michael B. Murphy; M J Brown; C T Dollery
Location of vascular alpha 2-adrenoceptors in man.
British journal of clinical pharmacology 1984;18(6):955-8.
1984: Michael B. Murphy; M J Brown; A J Scriven; D J Heavey; C T Dollery
Nifedipine and alpha adrenoceptor antagonism.
Clinical pharmacology and therapeutics 1984;36(6):745-9.
1984: A J Scriven; M J Brown; Michael B. Murphy; C T Dollery
Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure.
Journal of cardiovascular pharmacology 1984;6(5):954-60.
1984: M J Brown; D Harland; Michael B. Murphy; A D Struthers
Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans.
Hypertension 1984;6(5 Pt 2):II57-62.
1984: Michael B. Murphy; C J Bulpitt; C T Dollery
Role of nifedipine in the treatment of resistant hypertension. Comparison with hydralazine in hospital outpatients.
The American journal of medicine 1984;77(2B):16-21.
1984: Michael B. Murphy; D Sugrue; I Trayner; S Kaufman; H Yasuhara; C T Dollery; G R Thompson
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
British heart journal 1984;51(6):589-94.
1984: Michael B. Murphy; M X FitzGerald
Does hyperthyroidism predispose to thioridazine-induced hyperpyrexia and cardiac arrhythmias?
Postgraduate medical journal 1984;60(704):445-6.
1984: Michael B. Murphy; D J Reen; M X Fitzgerald
Atopy, immunological changes, and respiratory function in bronchiectasis.
Thorax 1984;39(3):179-84.
1984: Michael B. Murphy; M J Brown; C T Dollery
Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man.
European journal of clinical pharmacology 1984;27(1):23-7.
1983: M J Brown; D C Brown; Michael B. Murphy
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
The New England journal of medicine 1983;309(23):1414-9.
1983: Michael B. Murphy; A J Scriven; C T Dollery
Role of nifedipine in treatment of hypertension.
British medical journal (Clinical research ed.) 1983;287(6387):257-9.
1983: Michael B. Murphy; A J Scriven; C T Dollery
Efficacy of nifedipine as a step 3 antihypertensive drug.
Hypertension 1983;5(4 Pt 2):II118-21.
1983: A J Scriven; C T Dollery; Michael B. Murphy; I Macquin; M J Brown
Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine.
Clinical pharmacology and therapeutics 1983;33(6):710-6.
1983: Michael B. Murphy; R Causon
Hypotension and the pentolinium suppression test.
Lancet 1983;1(8335):1216.
1983: Michael B. Murphy; D Concannon; M X FitzGerald
Chest percussion: help or hindrance to postural drainage?
Irish medical journal 1983;76(4):189-90.
1983: Michael B. Murphy; M J Brown; R C Causon; C T Dollery
The effects of pentolinium on sympathetic activity in hypertensives and normotensive controls.
International journal of clinical pharmacology research 1983;3(4):227-32.
1982: Michael B. Murphy; P J Lewis; E Kohner; B Schumer; C T Dollery
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.
Lancet 1982;2(8311):1293-5.
1982: R C Causon; Michael B. Murphy; M J Brown
Effect of hemolysis on radioenzymic assay of plasma catecholamines.
Clinical chemistry 1982;28(3):548-50.
1982: Michael B. Murphy; A J Scriven; M J Brown; R Causon; C T Dollery
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity.
European journal of clinical pharmacology 1982;23(6):479-82.
1981: D J Reen; Michael B. Murphy; A O'Connor; M X FitzGerald
IgG sub-class levels in healthy Irish adults--a population study.
Irish journal of medical science 1981;150(9):265-9.
1980: Michael B. Murphy; A Dillon; M X Fitzgerald
Theophylline and depression.
British medical journal 1980;281(6251):1322.